Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Hepatology Communications|October 9, 2019
Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using MetabolomicsRichard D Khusial, Catherine E Cioffi, Shelley A Caltharp, et al.
Diabetes Care|June 16, 2021
Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE StudySteven E Kahn, Kieren J Mather, Silva A Arslanian, et al.
Diabetes Care|June 17, 2021
Effect of Medical and Surgical Interventions on α-Cell Function in Dysglycemic Youth and Adults in the RISE StudySteven E Kahn, Sharon L Edelstein, Silva A Arslanian, et al.
BMJ Open Diabetes Research & Care|July 24, 2020
Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youthCatherine E Cioffi, K M Venkat Narayan, Ken Liu, et al.
Obesity (Silver Spring, Md.)|May 26, 2021
Liver Fat Reduction After Gastric Banding and Associations with Changes in Insulin Sensitivity and β-Cell FunctionAnny H Xiang, Mayra P Martinez, Enrique Trigo, et al.
Diabetes|December 5, 2025
Altered Molecular Regulation of TUG Is a Central Feature of Insulin-Resistant Human Adipose TissueJordan W Strober, Kasper W Ter Horst, Daeun Sung, et al.
Diabetes Care|June 16, 2021
Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) StudySusan Sam, Sharon L Edelstein, Silva A Arslanian, et al.
Hepatology (Baltimore, Md.)|August 31, 2010
A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescentsNicola Santoro, Romy Kursawe, Ebe D'Adamo, et al.
Nature Communications|September 1, 2016
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levelsArvindhan Nagarajan, Max C Petersen, Ali R Nasiri, et al.
Obesity (Silver Spring, Md.)|July 27, 2022
Weight loss and β-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trialKristina M Utzschneider, David A Ehrmann, Silva A Arslanian, et al.
Pageof 18